These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

631 related items for PubMed ID: 28511684

  • 1. Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates.
    Khawaja K, Al-Maini M.
    Pediatr Rheumatol Online J; 2017 May 16; 15(1):41. PubMed ID: 28511684
    [Abstract] [Full Text] [Related]

  • 2. Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates.
    Khawaja K, Kalas R, Almasri N.
    Pediatr Rheumatol Online J; 2023 Feb 07; 21(1):14. PubMed ID: 36750870
    [Abstract] [Full Text] [Related]

  • 3. Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases.
    Yamazaki S, Shimbo A, Akutsu Y, Takase H, Morio T, Mori M.
    Pediatr Rheumatol Online J; 2020 Mar 23; 18(1):26. PubMed ID: 32293465
    [Abstract] [Full Text] [Related]

  • 4. Biologics in juvenile idiopathic arthritis: a narrative review.
    Vanoni F, Minoia F, Malattia C.
    Eur J Pediatr; 2017 Sep 23; 176(9):1147-1153. PubMed ID: 28725955
    [Abstract] [Full Text] [Related]

  • 5. Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
    Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J.
    Arthritis Care Res (Hoboken); 2016 Jan 23; 68(1):46-54. PubMed ID: 26212111
    [Abstract] [Full Text] [Related]

  • 6. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
    Kimura Y, Grevich S, Beukelman T, Morgan E, Nigrovic PA, Mieszkalski K, Graham TB, Ibarra M, Ilowite N, Klein-Gitelman M, Onel K, Prahalad S, Punaro M, Ringold S, Toib D, Van Mater H, Weiss JE, Weiss PF, Schanberg LE, CARRA Registry Investigators.
    Pediatr Rheumatol Online J; 2017 Apr 11; 15(1):23. PubMed ID: 28399931
    [Abstract] [Full Text] [Related]

  • 7. [Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care].
    Niewerth M, Minden K, Klotsche J, Horneff G.
    Z Rheumatol; 2014 Aug 11; 73(6):532-40. PubMed ID: 25096586
    [Abstract] [Full Text] [Related]

  • 8. Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
    Horton DB, Onel KB, Beukelman T, Ringold S.
    J Rheumatol; 2017 Mar 11; 44(3):352-360. PubMed ID: 28148696
    [Abstract] [Full Text] [Related]

  • 9. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
    Nigrovic PA, Beukelman T, Tomlinson G, Feldman BM, Schanberg LE, Kimura Y, Childhood Arthritis and Rheumatology Research Alliance Systemic Juvenile Idiopathic Arthritis Consensus Treatment Plan Workgroup.
    Clin Trials; 2018 Jun 11; 15(3):268-277. PubMed ID: 29542334
    [Abstract] [Full Text] [Related]

  • 10. Medical pathways of children with juvenile idiopathic arthritis before referral to pediatric rheumatology centers.
    Freychet C, Lambert C, Pereira B, Stephan JL, Echaubard S, Merlin E, Chausset A.
    Joint Bone Spine; 2019 Nov 11; 86(6):739-745. PubMed ID: 31121314
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
    Schmeling H, Minden K, Foeldvari I, Ganser G, Hospach T, Horneff G.
    Arthritis Rheumatol; 2014 Sep 11; 66(9):2580-9. PubMed ID: 24942886
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).
    Davies R, Carrasco R, Foster HE, Baildam EM, Chieng SEA, Davidson JE, Ioannou Y, Wedderburn LR, Thomson W, Hyrich KL.
    Semin Arthritis Rheum; 2016 Oct 11; 46(2):190-195. PubMed ID: 27422803
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Paediatric rheumatology practice in the UK benchmarked against the British Society for Paediatric and Adolescent Rheumatology/Arthritis and Musculoskeletal Alliance Standards of Care for juvenile idiopathic arthritis.
    Kavirayani A, Foster HE, British Society for Paediatric and Adolescent Rheumatology.
    Rheumatology (Oxford); 2013 Dec 11; 52(12):2203-7. PubMed ID: 24014649
    [Abstract] [Full Text] [Related]

  • 16. Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.
    Verazza S, Davì S, Consolaro A, Bovis F, Insalaco A, Magni-Manzoni S, Nicolai R, Marafon DP, De Benedetti F, Gerloni V, Pontikaki I, Rovelli F, Cimaz R, Marino A, Zulian F, Martini G, Pastore S, Sandrin C, Corona F, Torcoletti M, Conti G, Fede C, Barone P, Cattalini M, Cortis E, Breda L, Olivieri AN, Civino A, Podda R, Rigante D, La Torre F, D'Angelo G, Jorini M, Gallizzi R, Maggio MC, Consolini R, De Fanti A, Muratore V, Alpigiani MG, Ruperto N, Martini A, Ravelli A, Italian Pediatric Rheumatology Study Group.
    Pediatr Rheumatol Online J; 2016 Dec 20; 14(1):68. PubMed ID: 27993144
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
    Kimura Y, Schanberg LE, Tomlinson GA, Riordan ME, Dennos AC, Del Gaizo V, Murphy KL, Weiss PF, Natter MD, Feldman BM, Ringold S, CARRA STOP-JIA Investigators.
    Arthritis Rheumatol; 2021 Oct 20; 73(10):1898-1909. PubMed ID: 34105312
    [Abstract] [Full Text] [Related]

  • 19. Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register.
    McErlane F, Foster HE, Davies R, Lunt M, Watson KD, Symmons DP, Hyrich KL.
    Rheumatology (Oxford); 2013 Oct 20; 52(10):1905-13. PubMed ID: 23873820
    [Abstract] [Full Text] [Related]

  • 20. Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis.
    Luque Ramos A, Hoffmann F, Albrecht K, Klotsche J, Zink A, Minden K.
    Semin Arthritis Rheum; 2017 Oct 20; 47(2):269-275. PubMed ID: 28583690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.